Buckley Ventures Management Company Llc — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Mytosmytos.bio in 𝕏Seed · Sep 2023

Mytos builds robotic systems that automate the manufacturing of human cells, converting input stem cells into specific cell types such as neurons and heart cells over multiple weeks.

Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical DevicesRoboticsLondon, GB

Ali Afshar(CEO)inIgnacio Willats(Founder)inHenry Miskin(Developer)James Cunningham(Hardware Design Engineer)Jack Owen(Operations)Sam O'Mahony(Senior Electronics Engineer)

PartnerJosh Buckley· solo GP

Co-investorsY Combinator Acequia Capital (AceCap)Artis Ventures Deep Science Ventures Emles Venture Partners IQ Capital +12 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.